184 related articles for article (PubMed ID: 8089668)
21. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
Leach JP; Girvan J; Paul A; Brodie MJ
J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
[TBL] [Abstract][Full Text] [Related]
22. Pregabalin as adjunctive therapy for partial seizures.
Brodie MJ
Epilepsia; 2004; 45 Suppl 6():19-27. PubMed ID: 15315512
[TBL] [Abstract][Full Text] [Related]
23. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
[TBL] [Abstract][Full Text] [Related]
24. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
25. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
French J; Brandt C; Friedman D; Biton V; Knapp L; Pitman V; Chew M; Dubrava S; Posner HB
Epilepsia; 2014 Aug; 55(8):1220-8. PubMed ID: 24962242
[TBL] [Abstract][Full Text] [Related]
26. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
[TBL] [Abstract][Full Text] [Related]
27. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy.
Gillham RA; Blacklaw J; McKee PJ; Brodie MJ
J Neurol Neurosurg Psychiatry; 1993 Dec; 56(12):1271-5. PubMed ID: 8270925
[TBL] [Abstract][Full Text] [Related]
28. Quantitative MR relaxometry study of effects of vigabatrin on the brains of patients with epilepsy.
Jackson GD; Grünewald RA; Connelly A; Duncan JS
Epilepsy Res; 1994 Jun; 18(2):127-37. PubMed ID: 7957035
[TBL] [Abstract][Full Text] [Related]
29. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
[TBL] [Abstract][Full Text] [Related]
30. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
31. Gamma-vinyl GABA (vigabatrin) and mood disturbances.
Aldenkamp AP; Vermeulen J; Mulder OG; Overweg J; Van Parys JA; Beun AM; Van 't Slot B
Epilepsia; 1994; 35(5):999-1004. PubMed ID: 7925172
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of first-line vigabatrin monotherapy in childhood partial epilepsies.
Gobbi G; Pini A; Bertani G; Menegati E; Tiberti A; Valseriati D; Besana D; Rasmini P; Guerrini R; Belmonte A; Veggiotti P; Resi C; Lanzi G; Capovilla G; Galeone D; Milani S
Epilepsy Res; 1999 May; 35(1):29-37. PubMed ID: 10232792
[TBL] [Abstract][Full Text] [Related]
33. Vigabatrin use in 72 patients with drug-resistant epilepsy.
Buchanan N
Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.
Beran RG; Berkovic SF; Buchanan N; Danta G; Mackenzie R; Schapel G; Sheean G; Vajda F
Seizure; 1996 Dec; 5(4):259-65. PubMed ID: 8952010
[TBL] [Abstract][Full Text] [Related]
35. Rationalized polytherapy for epilepsy.
Goldsmith P; de Bittencourt PR
Acta Neurol Scand Suppl; 1995; 162():35-9. PubMed ID: 7495188
[TBL] [Abstract][Full Text] [Related]
36. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
Yamauchi T; Kaneko S; Yagi K; Sase S
Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?
McKee PJ; Blacklaw J; Friel E; Thompson GG; Gillham RA; Brodie MJ
Epilepsia; 1993; 34(5):937-43. PubMed ID: 8404750
[TBL] [Abstract][Full Text] [Related]
38. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group.
Lhoir A
Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
40. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children.
Zamponi N; Cardinali C
Arch Neurol; 1999 May; 56(5):605-7. PubMed ID: 10328256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
